The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Which is more accurate for predicting OS and TTFT, CLL-IPI or MDACC-PI?

Nov 16, 2016

Massimo Gentilefrom the Azienda Ospedaliera of Cosenza, Consenza, Italy, and colleagues from across Italy and the US recently published data in a letter to the editor on the topic of comparing two prognostic tools for CLL in a community based cohort in Blood, October, 2016. The authors set out to compare and assess the validity of the recently published CLL-IPIand the MD Anderson Cancer Center Prognostic Index(MDACC-PI) scores for predicting OS and TTFT in newly diagnosed CLL patients. The data was collected from 858 patients across 5 Italian centers and, in a separate data set, 506 patients at the Mayo Clinicin the US.


  • 5-year OS of CLL-IPI groups in this study, similar to original publication
  • OS C-statistic: CLL-IPI = 0.71 (P<0.0001) vs. MDACC-PI = 0.68 (P<0.001)
  • TTFT C-statistic: CLL-IPI = 0.72 (P<0.001) vs. MDACC-PI = 0.63 (P<0.001)
  • Mayo Clinic OS C-statistic: CLL-IPI 0.75 (P<0.001) vs. MDACC-PI = 0.66 (P<0.001)
  • Mayo Clinic TTFT C-statistic: CLL-IPI 0.74 (P<0.001) vs. MDACC-PI = 0.66 (P<0.001)

The CLL-IPI is a more accurate prognostic predictor than MDACC-PI in terms of both OS and TTFT, in two separate populations, confirming the use of CLL-IPI. However, as MDACC-PI can be used without FISH (TP53) or IGHV, unlike CLL-IPI, it may still be useful in some settings. When taken together, this work validates the CLL-IPI for use in predicting both OS and TTFT in patients with newly diagnosed CLL.  

  1. Gentile M. et al. Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients. Blood. Oct 2016; 128:2093–2095. doi: 10.1182/blood-2016-07-728261.
  2. International CLL-IPI working group. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data. Lancet Oncology. 2016 Jun; 17(6):779–790. doi: 10.1016/S1470-2045(16)30029-8. Epub 2016 May 13.
  3. Wierda W.G. et al. Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia. Blood. 2007 Jun 1; 109(11):4679–4685. Epub 2007 Feb 13.